Mismatched ribosome assembly may make muscle recovery limit fasting-mimetic lifespan gains
In old mice, muscle protein production between fasting-mimetic cycles may outpace ribosome assembly, causing toxic protein buildup and limiting lifespan gains. Shorter life after blocking this recovery, despite normal ribosome assembly, would count against the hypothesis.
Stage of verification
- Hypothesis published2026-10-06
- Indirect evidenceAssessed at 4 of 10
- Direct testAwaited
Map of the hypothesis
Hover over an icon or tap it to see its name.
Where in the body
Biological function
Kind of knowledge gap
A double ring marks the main placement where a group contains several values.
Target map
Every target of every published hypothesis, each with the actions a hypothesis can propose on it. The targets and the actions of this hypothesis are drawn solid.
Metabolism and energy
Protein translation
The process by which cells synthesize proteins
Where this hypothesis actsIn muscles of old mice during recovery between fasting-mimetic cycles
Hypotheses on this target 6
Inhibition1
Activation
Function preservation
Supplementation
Feedback restoration
Direct measurement
What is proposed
Suppress the recovery surge in ribosomal protein synthesis
HowReversibly alter muscle translation genetically while preserving basal renewal of contractile proteins
Possible result
Possible greater lifespan extension with fewer unassembled ribosomal proteins, despite reduced muscle mass gain
From the recordПерспективный компонент такого миметика должен ограничивать избыточное производство рибосомных белков при сохранении базового обновления сократительных белков.
Rhythm or programme
Ribosome assembly
The process of assembling ribosomal proteins and ribosomal RNA into ribosomes
Where this hypothesis actsIn old muscle when ribosomal protein synthesis resumes ahead of ribosomal RNA maturation
Hypotheses on this target 1- Inhibition
- Activation
- Function preservation
- Feedback restoration
Rhythm restoration1- Direct measurement
What is proposed
Rhythm restoration
Coordinate ribosomal protein synthesis with ribosomal RNA maturation
With whatNot stated in the record
HowA means of selectively coordinating ribosome assembly in old muscle remains to be developed
Possible result
Possible prevention of proteotoxicity while preserving the amplitude of the anabolic surge
From the recordРешающий результат: согласование сборки рибосом устранит вред всплеска при сохранении его амплитуды.
All targets of the lab
Every target read from the published hypotheses, each kind around its pictogram. A larger mark means more hypotheses act on that target. Point at a mark and the actions proposed on it branch out of it.
Solid and named: the targets of this hypothesis
Explore in depth
The logic
The train of thought that ends in this hypothesis. Each stage is the reason the next exists. The master question narrows to a goal, the goal to an unknown nobody has closed, the unknown to the hypothesis proposed here. Every step below says what it rests on and what carries it.
Repeated treatments that imitate fasting may depend on what happens in muscle between treatments. The unexpected proposal is that part of muscle recovery could be harmful because components of its protein-making machinery are produced before they can be assembled. This is a hypothesis generated by the pipeline, not a measured result: it predicts that restraining the excess could increase lifespan benefit even while reducing muscle growth.
- Between fasting-mimetic treatments, old muscle resumes protein production.
- Production of ribosomal proteins is proposed to restart faster than ribosomal ribonucleic acid matures.
- Coordinated assembly is proposed to give way to excess production, leaving ribosomal proteins outside completed ribosomes.
- The unassembled proteins are proposed to accumulate and damage muscle cells.
- That repeated damage is proposed to reduce the treatment’s lifespan benefit.
- Selectively restraining excess component production while preserving basic replacement of contraction proteins is predicted to reduce damage and increase lifespan benefit.
A workshop receives chair legs faster than seats arrive, so extra legs pile up instead of becoming usable chairs. Slowing leg deliveries could clear the workshop even though fewer parts arrive.
Where the picture breaks: Cells can remove or reuse unassembled components, and a pile of spare parts does not explain why proteins would damage cells. The proposed mismatch, accumulation and resulting harm each require measurement.
- Master questionstep 01 of 04
Imitating beneficial processes that occur naturally in the body might yield new ways to extend life.
Rests on: The supplied goal explicitly calls for proposed substances, combinations or other interventions that reproduce useful effects of natural bodily processes.
Stated in the chain - Goal pillarstep 02 of 04
Repeated treatments are examined through whether each cycle of the body’s response reaches completion.
Rests on: The master question seeks useful processes to imitate, but does not identify completion between repeated treatments as a requirement.
AssumptionCompletion of repeated response cycles is taken as a relevant organizing principle for finding life-extending interventions; the master question supplies no explanation for choosing it.
- Gap questionstep 03 of 04
A fasting mimetic, an intervention intended to reproduce effects of fasting, might retain or lose its lifespan benefit when muscle anabolism, the rebuilding of muscle material, is selectively prevented between treatments. Suppression of the treatment’s main biological target in other tissues is held unchanged.
Rests on: The preceding stage makes completion between cycles the focus; this stage selects muscle rebuilding as the part whose contribution must be separated from effects elsewhere.
AssumptionMuscle rebuilding during recovery is selected as a potentially decisive part of cycle completion. The preceding stage does not supply a basis for that specific choice, and the treatment and its main target are not identified.
- Hypothesisstep 04 of 04
In old mice, muscle rebuilding between treatments is proposed to become harmful when production of ribosomal proteins, the protein components of ribosomes, outruns maturation of ribosomal ribonucleic acid, the other major material required to assemble them. Unassembled proteins are proposed to accumulate and cause proteotoxicity, cellular damage from problematic proteins. Limiting the excess while preserving replacement of proteins that make muscle contract is predicted to increase lifespan benefit despite less muscle growth.
Rests on: The preceding question isolates recovery in muscle from treatment effects elsewhere. The hypothesis supplies a proposed reason that recovery could reduce benefit: production of the two kinds of ribosome components becomes mismatched.
Stated in the chain
What is carried, and what is not. None of the three screened sources directly establishes any of the proposed causal links from mismatched assembly through protein damage to a reduced lifespan benefit. The sequence is an explicitly stated hypothesis, and no supplied evidence establishes it from beginning to end.
Where the reasoning is carried by something unstated · 2
- Goal pillar. Completion of repeated response cycles is taken as a relevant organizing principle for finding life-extending interventions; the master question supplies no explanation for choosing it.
- Gap question. Muscle rebuilding during recovery is selected as a potentially decisive part of cycle completion. The preceding stage does not supply a basis for that specific choice, and the treatment and its main target are not identified.
How a result here could mislead · 3
- Longer survival after suppressing muscle recovery could be credited to a stronger fasting-mimetic benefit when the muscle intervention itself changes survival. What closes it: The comparison requires animals receiving the same muscle intervention with and without the fasting mimetic, alongside corresponding groups without that intervention. Suppression of the treatment’s main target outside muscle must also be verified as unchanged.
- Fewer unassembled ribosomal proteins after suppressing protein production could be mistaken for proof that assembly mismatch caused harm. Producing fewer components could lower that quantity without correcting their relative timing. What closes it: Measurements must connect the timing of component production and ribosomal ribonucleic acid maturation to the unassembled fraction and cellular damage. The decisive proposed comparison preserves the size of the recovery burst while correcting assembly; the supplied material says an intervention capable of doing that still needs development.
- Shorter survival after blocking recovery could be read as a rejection of the mismatch hypothesis even if the intervention also prevents necessary muscle repair or restoration of the cell’s waste-processing machinery. What closes it: Interpretation requires verification of what the intervention actually suppresses, including whether basic replacement of contraction proteins and cellular waste processing remain functional. The proposed genetic alteration of muscle protein production is not specified sufficiently to establish that selectivity.
What would make this wrong. The central explanation would fail if verified coordination of ribosome assembly, with the recovery burst preserved, removed the excess unassembled proteins but left the proposed cellular damage and loss of lifespan benefit unchanged. The supplied hypothesis also identifies shorter life after blocking recovery despite normal ribosome assembly as evidence favoring required muscle repair or restoration of cellular machinery instead.
What it would change. If the hypothesis held, the search for life-extending imitations of natural processes would need to consider coordination of recovery, rather than treating the amount of rebuilding as sufficient to describe its benefit. A candidate intervention would aim to keep production of protein-making machinery matched to assembly capacity while preserving necessary muscle repair. Even a positive result in old mice would leave effects in humans, other tissues and other fasting-mimetic treatments unestablished; the supplied material names no substance that achieves the required selective coordination.
Sources read · 3
Age-Related Changes in Sirtuin 7 Expression in Calorie-Restricted and Refed Rats. · Gerontology · 2016
“In old rats' EDL and SOL muscles, SIRT7 protein expression was inhibited by refeeding.”
Does not settle: The source does not establish mismatched ribosome assembly, differential timing of ribosomal-protein synthesis and rRNA maturation, accumulation or proteotoxicity of free ribosomal proteins, effects on contractile-protein turnover, muscle mass, repeated fasting cycles, or lifespan. It also does not test a fasting mimetic or selective suppression of recovery-phase muscle protein synthesis.
Sexually Dimorphic Response to Dietary Restriction-induced Longevity and Muscle Rejuvenation in Nothobranchius furzeri. · bioRxiv : the preprint server for biology · 2026
“Notably, under IF, both sexes exhibit upregulation of ribosome biogenesis and genes supporting myofibrillar organization and contraction, likely underlying preserved muscle function.”
Does not settle: The source does not study old mice, refeeding-cycle recovery, the relative timing of ribosomal-protein synthesis and rRNA maturation, accumulation of free ribosomal proteins, proteotoxicity, muscle-selective suppression of anabolic recovery, preservation of contractile-protein turnover, or SPV_7 stabilization.
Inositol Hexakisphosphate Kinase 3 Regulates Metabolism and Lifespan in Mice. · Scientific reports · 2016
“Notably, Ip6k3 deletion extended animal lifespan with concomitant reduced phosphorylation of S6 ribosomal protein in the heart. In contrast, Ip6k3 −/− mice showed unchanged skeletal muscle mass and no resistance to the effects of high fat diet.”
Does not settle: The source does not establish fasting–refeeding cycle effects in old mice, recovery of muscle anabolism, differential timing of ribosomal-protein synthesis and rRNA maturation, accumulation or proteotoxicity of free ribosomal proteins, selective suppression of a post-fast synthesis surge, preservation of contractile-protein turnover, or stabilization of SPV_7.
The gap this hypothesis explains
Two live hypotheses pull in opposite directions here, and the field has not chosen between them.
Does a fasting-like treatment still extend life if muscle rebuilding cannot recover between treatments?
Original wording · exactly as the pipeline generated it
Сохранит ли миметик голодания продление жизни при избирательном устранении межциклового восстановления мышечного анаболизма, если подавление его основной мишени в остальных тканях остаётся прежним?
What this question is asking
The question asks whether a treatment's life-extending effect depends on muscles regaining their ability to build proteins between treatment cycles. It concerns a fasting mimetic, meaning a treatment intended to reproduce some effects of fasting, whose stated target is mechanistic target of rapamycin, or mTOR, a regulator of cell growth and metabolism. The comparison is between the same treatment with muscle recovery preserved and with that recovery selectively prevented, while target suppression in other tissues remains unchanged. The pipeline assumes that intermittent target suppression extends mouse lifespan and asks whether this benefit survives the loss of muscle recovery. Its stated recovery requirement is that muscles respond again by the next usual physical load and that repeated treatment does not lengthen their period of reduced responsiveness.
- Fasting mimetic
- A treatment intended to reproduce some biological effects of fasting. This names a class of intended effects, not a single substance or a guarantee that all effects of fasting are reproduced.
- Mechanistic target of rapamycin (mTOR)
- A regulator involved in cell growth and metabolism. The pipeline identifies its suppression as the treatment's main action.
- Mechanistic target of rapamycin complex 1
- A signaling assembly containing the target regulator that participates in controlling growth and protein building. S1 connects its activity to nutrient availability; S3 shows that sustained signaling need not mean sustained muscle protein production.
- Muscle anabolism or muscle rebuilding
- The building side of muscle maintenance, including production of muscle proteins. Recovery here means restoration of that building response between treatments, not necessarily a demonstrated increase in muscle size.
- Muscle protein synthesis
- The production of new proteins in muscle. It is a process contributing to muscle rebuilding, rather than a direct measurement of lifespan.
- Reduced responsiveness
- A smaller protein-building response despite continued stimulation. S3 describes this phenomenon, but does not establish its duration across the proposed treatment cycles.
- Essential amino acids and leucine
- Essential amino acids are protein building blocks that must come from the diet; leucine is one of them. S1 discusses their availability as an influence on growth-related signaling.
- Skeletal muscle and resistance training
- Skeletal muscles produce body movement. Resistance training loads these muscles against resistance, and S2 links their subsequent recovery to temporary increases in protein production.
- Ribosomes
- The cellular machinery that builds proteins. S4 relates their abundance to the capacity for muscle recovery after early undernutrition.
- Catch-up growth
- Accelerated growth during recovery from an earlier growth shortfall. In S4 it concerns development after undernutrition, rather than recovery between fasting-like treatment cycles.
- Myotis lucifugus and hibernation
- Myotis lucifugus is the bat species studied in S7. Hibernation includes periods of greatly reduced bodily activity; the supplied description concerns predicted signaling changes during that state.
- Rapamycin
- A substance described in S8 as inhibiting mechanistic target of rapamycin signaling. Its reported survival effect concerns the particular disease-model mice studied there.
- Fxn conditional inactivation and Friedreich ataxia model
- S8 concerns mice in which the gene identified as Fxn was switched off in selected tissues to model aspects of Friedreich ataxia, a disease. This specific altered background limits what its survival finding establishes about ordinary aging.
- RL-1
- An identifier supplied by the pipeline alongside its claim about intermittent target suppression and mouse lifespan. The provided material does not establish what it denotes.
Intermittent mTOR suppression, identified in the pipeline as RL-1, is associated with longer mouse lifespan, and muscle rebuilding recovers between cycles without a progressively longer period of reduced responsiveness.
The assumption concerns mice receiving repeated treatment that temporarily suppresses a regulator of cell growth. It treats longer life and recovery of muscle protein building before the next usual physical load as the starting conditions. If those conditions hold, the remaining question is whether removing muscle recovery removes the lifespan benefit.
The supplied sources do not establish this starting combination. S1 and S2 concern protein building around exercise, and S3 describes reduced responsiveness of muscle protein production despite continued nutrient availability and growth-related signaling. S8 reports improved survival after target suppression in mice with a specific disease-related genetic alteration, which does not establish longer natural lifespan under the intermittent treatment described here. The supplied search results contain no work establishing the RL-1 claim or stable recovery across repeated treatment cycles; this does not show that either claim is false.S1S2S3S8
The same question asked without the part nothing read establishes:
- During intermittent suppression of mechanistic target of rapamycin, does preventing muscle rebuilding from recovering between cycles change lifespan when suppression in other tissues stays the same?
- Does a fasting-like treatment's effect on lifespan depend on muscle rebuilding recovering between treatment cycles?
- The lifespan benefit is preserved If a lifespan benefit is first established and remains unchanged when muscle recovery is selectively prevented, that recovery would not be necessary for the benefit under those conditions. This would establish a separation between the lifespan outcome and that particular muscle response, without establishing that muscle health is unaffected.
- The lifespan benefit disappears If selective prevention of recovery removes an established lifespan benefit while suppression elsewhere stays unchanged, that would support a necessary contribution from muscle recovery under those conditions. Continued target suppression in other tissues would then be insufficient to preserve the benefit.
- The lifespan benefit becomes smaller If preventing recovery reduces but does not eliminate an established benefit, muscle recovery would contribute to its magnitude without accounting for all of it. The remaining extension of life would show that some benefit persists without that recovery, while leaving its explanation unsettled.
The proposed chain begins with temporary suppression of a growth-regulating target, followed by an interval in which muscle protein building can recover. Temporary increases in muscle protein production after exercise contribute to muscle growth, according to S2. Whether that recovery also helps preserve a treatment's lifespan benefit is a separate causal link that the supplied sources do not establish. If recovery is necessary, treating target suppression alone as sufficient would misidentify what produces the benefit. If recovery is unnecessary for that benefit, assuming otherwise would incorrectly make muscle recovery a condition for life extension.
Импульсное подавление mTOR, RL-1, связано с продлением жизни мышей; необходимость восстановительной фазы причинно не установлена.
Мышечный ответ восстанавливается до следующей обычной нагрузки; период нечувствительности не увеличивается при повторении.
Неизвестно, исчезает ли выигрыш продолжительности жизни при избирательном устранении восстановления и сохранении остальных эффектов миметика.
The mechanism it proposes
The engine's own statement of the hypothesis, in full.
У старых мышей межцикловое восстановление мышечного анаболизма может ограничивать продление жизни миметиком голодания. Предполагаемый механизм состоит в том, что возобновление синтеза рибосомных белков опережает созревание рибосомной РНК. Свободные рибосомные белки накапливаются и вызывают протеотоксичность. Поэтому избирательное подавление восстановительного всплеска синтеза в мышцах усилит выигрыш продолжительности жизни, хотя прирост мышечной массы уменьшится. Физиологическим прототипом нового миметика служит согласованная сборка рибосом после голодания. Перспективный компонент такого миметика должен ограничивать избыточное производство рибосомных белков при сохранении базового обновления сократительных белков. Это могло бы стабилизировать SPV_7 через снижение повреждений при повторении циклов.
Testing and possible results
The prediction that would tell it apart
A hypothesis that predicts what its rivals predict is not worth running an experiment over. This is the observation on which this one differs.
При подтверждённом подавлении межциклового синтеза белка мышечно-специфическое вмешательство увеличит дополнительный выигрыш жизни от миметика и уменьшит долю рибосомных белков вне собранных рибосом. Принудительное восстановление анаболического всплеска вернёт протеотоксичность и сократит этот выигрыш. Решающий результат: согласование сборки рибосом устранит вред всплеска при сохранении его амплитуды. Если блокирование восстановления сокращает жизнь при нормальной сборке рибосом, гипотеза уступает механизмам обязательного структурного или органелльного восстановления.
Would tell it apart from at least one rival. The prediction specifies directional changes in lifespan benefit and ribosomal protein distribution, elimination of harm under a stated condition, and an explicit rejection condition. No rival prediction is supplied. Only a bench experiment would settle it.
What testing it would take
The engine's own read on whether this is testable with methods that already exist.
Полисомное фракционирование, количественная протеомика и измерение созревания рибосомной РНК позволяют проверить предполагаемое рассогласование. Обратимое изменение мышечной трансляции возможно генетически. Средство, избирательно согласующее сборку рибосом в старой мышце, ещё требуется разработать; это ограничивает готовность решающего опыта.
Other explanations
Every other hypothesis the engine wrote for the same gap, and the observation that would separate the two.
При подтверждённом подавлении межциклового синтеза белка мышечно-специфическое вмешательство увеличит дополнительный выигрыш жизни от миметика и уменьшит долю рибосомных белков вне собранных рибосом. Принудительное восстановление анаболического всплеска вернёт протеотоксичность и сократит этот выигрыш. Решающий результат: согласование сборки рибосом устранит вред всплеска при сохранении его амплитуды. Если блокирование восстановления сокращает жизнь при нормальной сборке рибосом, гипотеза уступает механизмам обязательного структурного или органелльного восстановления.
- What would separate them
Persistent muscle stromal cells may erase lifespan gains from fasting mimetics predicts: После блокирования межциклового анаболизма численность фиброзно-жировых предшественников начнёт увеличиваться от цикла к циклу раньше выраженного фиброза. Избирательное возвращение их численности к физиологическому диапазону восстановит выигрыш жизни при сохранённом подавлении мышечного синтеза белка. Краткое восстановление анаболизма поможет только до закрепления патологической структуры сообщества. Если численность и судьба этих клеток остаются нормальными, а их избирательное ограничение не помогает, гипотеза уступает внутриклеточным механизмам.
- What would separate them
Suppressing fatal disease outside muscle may preserve a mimetic’s lifespan benefit predicts: В факторном сравнении миметика и мышечного блокирования последнее ухудшит силу и анаболический ответ, но дополнительный выигрыш жизни от миметика сохранится в заранее установленной полосе эквивалентности. Снижение частоты или отсрочка смертельных опухолей также сохранится. Восстановление мышечной функции улучшит функциональные показатели, почти не изменив дополнительного выигрыша жизни. Гипотеза опровергается, если избирательное возвращение мышечного восстановления возвращает утраченный эффект миметика на выживаемость при сопоставимой патологии остальных тканей.
- What would separate them
Incomplete sarcomere repair may erase a fasting mimetic's lifespan benefit predicts: При одинаковом подавлении общего синтеза белка потеря эффекта миметика будет зависеть от механической нагрузки и сопровождаться незавершённой заменой филамина C в Z-дисках. Избирательное восстановление его встраивания улучшит удельную силу и сохранит выигрыш жизни при низком общем анаболизме. Нормализация только численности стромальных клеток или только лизосомного цикла окажется недостаточной. Сохранность Z-дисков и отсутствие зависимости от нагрузки при утрате выигрыша жизни опровергнут этот механизм.
- What would separate them
Failed lysosome reformation may erase a fasting mimic's lifespan benefit predicts: Продолжительное подавление мышечного mTORC1 уменьшит повторное образование лизосом, ухудшит деградацию аутофагического груза в поздних циклах и устранит выигрыш жизни. При сопоставимом подавлении синтеза белка через отдельную трансляционную ветвь, сохраняющую лизосомный цикл, выигрыш останется. Восстановление именно преобразования мембран аутолизосом вернёт эффект миметика при низком анаболизме. Если оба способа подавления трансляции одинаково сокращают жизнь при нормальной лизосомной функции, гипотеза уступает структурному механизму.
Why this is not the mainstream account
The engine is asked to say what its hypothesis would overturn and what would surprise a specialist. This is its answer.
В модели воздействия аргинин-богатых пептидов снижение общей трансляции сочеталось с накоплением свободных рибосомных белков; подавление mTOR или MYC уменьшало токсичность, а рапамицин ослаблял ускоренное старение мышей. Это показывает возможность расхождения между количеством синтеза и качеством сборки, но непосредственно межцикловой мышечный анаболизм не проверяет. [Sirozh et al., 2024](https://doi.org/10.1016/j.molcel.2024.02.031).
Геронтология скелетной мышцы; учебная глава «Саркопения и анаболическая резистентность». Пересмотра потребует представление, что восстановление физиологического анаболического ответа после катаболической фазы обязательно улучшает долговременный исход. Здесь предполагается обратный эффект именно восстановительного всплеска в старой мышце.
Возвращение мышечного анаболического всплеска в физиологический диапазон сократит жизнь на фоне миметика, одновременно улучшив мышечную массу; устранение избытка несобранных рибосомных белков снимет это противоречие.
В целевом поиске прямое утверждение о продлении жизни обычных старых мышей посредством устранения межциклового мышечного анаболизма из-за рассогласованной сборки рибосом не найдено. Общая польза ограничения трансляции и связь ядрышкового стресса со старением уже известны. Исчерпывающее отсутствие аналогичной гипотезы в литературе не установлено; статус HERETICAL остаётся предварительным.
What stands behind it
Which of the figures above have a study behind them, which are the engine's own, and what it would take to refute the hypothesis. This audit never judges the idea.
This hypothesis states no figure and cites no study, so there is nothing here to trace.
What it would take to refute it. Nothing already retrieved carries the prediction’s terms and it names no measurement this layer can route to a public dataset, so the bench is the residual — not a finding against it.
0 citation handles extracted; 1 Europe PMC search run; 0 records examined; 0 sources stored for enrichment, 0 with full text. A citation that did not resolve is a bibliographic failure, not proof that no such paper exists, and no hypothesis is blocked by this audit.